These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Habituation of blink reflexes in parkinsonian patients under levodopa and amantadine treatment. Messina C; Di Rosa AE; Tomasello F J Neurol Sci; 1972 Oct; 17(2):141-8. PubMed ID: 4340932 [No Abstract] [Full Text] [Related]
3. Impaired potentiation of H-reflexes in patients with Parkinson's disease. Sica RE; Aguilera N; Herskovits E Medicina (B Aires); 1972; 32(6):588-95. PubMed ID: 4663253 [No Abstract] [Full Text] [Related]
4. An electrophysiological study of some trigeminofacial reflexes in Parkinson's disease before and after L-dopam administration. Caccia MR; Avanzini G; Negri S Eur Neurol; 1972; 8(6):339-51. PubMed ID: 5087019 [No Abstract] [Full Text] [Related]
5. Treatment of Parkinson's disease with amantadine and L-Dopa. Rinne UK; Sonninen V; Siirtola T Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618 [No Abstract] [Full Text] [Related]
6. Amantadine and levodopa in the treatment of Parkinson's disease. Walker JE; Potvin A; Tourtellotte W; Albers J; Repa B; Henderson W; Snyder D Clin Pharmacol Ther; 1972; 13(1):28-36. PubMed ID: 4550321 [No Abstract] [Full Text] [Related]
13. Comparison of amantadine, placebo, and levodopa in Parkinson's disease. Bauer RB; McHenry JT Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417 [No Abstract] [Full Text] [Related]
14. Muscle silent period in Parkinson's disease. Higgins DC; Haidri NH; Wilbourn AJ J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):508-11. PubMed ID: 4256387 [TBL] [Abstract][Full Text] [Related]
15. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine]. Sigwald J; Raymondeaud C; Piot C Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718 [No Abstract] [Full Text] [Related]
16. [Action of amantadine HCl alone and in combination with L-dopa on parkinsonism]. Danielczyk W; Korten JJ Med Monatsschr; 1971 Oct; 25(10):472-9. PubMed ID: 5122447 [No Abstract] [Full Text] [Related]
17. L-dopa and amantadine hydrochloride in Parkinson's disease. Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417 [No Abstract] [Full Text] [Related]
18. [Effects induced by the treatment with amantadine on habituation of trigemino-facial reflexes in Parkinsonian patients]. Messina C; Tomasello F Riv Neurol; 1972; 42(2):202-8. PubMed ID: 4341955 [No Abstract] [Full Text] [Related]
19. [Drug therapy of Parkinson's disease with amantadine and levodopa]. Fieschi C; Nardini M; Casacchia M; Reitano M; Tedone ME; Ferrari P; Robotti E Sist Nerv; 1970; 22(2):126-43. PubMed ID: 5504552 [No Abstract] [Full Text] [Related]
20. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa]. Fieschi C; Casacchia M; Nardini M; Reitano N Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075 [No Abstract] [Full Text] [Related] [Next] [New Search]